This article is available to subscribers. Subscribe now. Already have an account? Sign in

Original ArticleFree PreviewArchive

Treatment of Malignant Ventricular Arrhythmias with Endocardial Resection and Implantation of the Automatic Cardioverter-Defibrillator

List of authors.
  • Edward V. Platia, M.D.,
  • Lawrence S.C. Griffith, M.D.,
  • Levi Watkins, Jr., M.D.,
  • Morton M. Mower, M.D.,
  • Thomas Guarnieri, M.D.,
  • M. Mirowski, M.D.,
  • and Philip R. Reid, M.D.

Abstract

Although ventricular resection guided by endocardial mapping has been a successful treatment for drug-refractory ventricular arrhythmias, 20 to 30 percent of patients still have postoperative sustained ventricular tachycardia or sudden death. To improve the outcome of the procedure, we implanted an automatic cardioverter-defibrillator in conjunction with endocardial resection in 28 patients, all of whom had had previous myocardial infarctions and between one and five cardiac arrests. There were three perioperative deaths. During follow-up of 8 to 51 months (mean, 25), 4 of the 25 survivors had recurrences of hypotensive ventricular tachycardia, which in all instances were automatically terminated by the implanted device. One patient, whose automatic cardioverter-defibrillator was not functional, died suddenly.

We conclude that patients undergoing mapping-directed endocardial resection can be provided with additional protection against recurrent ventricular tachyarrhythmias or sudden death by implantation of an automatic cardioverter-defibrillator. (N Engl J Med 1986; 314:213–6.)

Funding and Disclosures

We are indebted to Sandra Waclawski, R.N., and Frank Wenham for technical assistance, to Susan Trafton Edmunds for editorial review, and to Karyl Plaud Fleck and Lisa Wade for assistance in the preparation of the manuscript.

Note added in proof: Since acceptance of this paper, another of the 28 patients had a documented episode of hypotensive, sustained ventricular tachycardia, which was terminated by discharge of the automatic cardioverter-defibrillator, 19 months after surgery.

Author Affiliations

From the Departments of Medicine and Cardiovascular Surgery, The Johns Hopkins Medical Institutions, Baltimore; and the Department of Medicine, The Washington Hospital Center, Washington, D.C. Address reprint requests to Dr. Platia at the Cardiac Arrhythmia Center, Washington Heart, Washington Hospital Center, 110 Irving St. NW, Washington, DC 20010.

In accordance with the Journal's policy regarding disclosure, the authors state that Dr. Mirowski holds patents on the device described in this article. Also, Drs. Mirowski and Mower serve as consultants to its manufacturer.

Print Subscriber? Activate your online access.